FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to immunology and medicine, namely to new peptides of general formula: X-CC-C(Y)-CC-Z, wherein X is a B-cell epitope of apolipoprotein B100 protein; C is an amino acid residue specified in K or R; Y is an immunoadjuvant specified in a group of Pam1CSS-; Pam2CSS-, Pam3CSS-; Z - T-helper epitope specified in AKFVAAWTLKAAA, KLIPNASLIENCTKAEL, QYIKANSKFIGITE.
EFFECT: peptide preparations possess higher antisclerotic activity as compared to their analogues, and the compositions thereof are of practical interest as a vaccine for preventing and treating atherosclerotic vascular disease.
9 cl, 1 dwg, 6 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
WOUND-HEALING COMPOSITION | 1993 |
|
RU2122401C1 |
IMMUNOTHERAPEUTIC TREATMENT | 2006 |
|
RU2454428C2 |
METHOD OF PROPHYLAXIS AND TREATMENT OF PARASITIC AND INFECTIOUS DISEASE USING INTERLEUKIN-1 | 1995 |
|
RU2090208C1 |
PROMOTING AGENT OF PROLIFERATION OF REGULATORY T-LYMPHOCYTE, AND THEIR PROMOTION METHOD | 2012 |
|
RU2499043C1 |
METHOD OF DETERMINING PROINFLAMMATORY AND PROALLERGIC INTERLEUKINS IN NASAL SECRETION IN INFANTS AND PRESCHOOL CHILDREN FOR DIAGNOSTICS OF AETIOLOGY OF RECURRING ACUTE RHINOPHARYNGITIS AND ADENOIDITIS | 2013 |
|
RU2569054C2 |
METHOD OF DIAGNOSING DYSBIOTIC DISORDERS IN BIOPSIES OF NASAL MUCOSA, PHARYNX IN INFANTS AND PRESCHOOL CHILDREN WITH CONSTANTLY RECURRENT ACUTE RESPIRATORY INFECTIONS | 2013 |
|
RU2576839C2 |
AC-HIS-ALA-GLU-GLU-NH PEPTIDE PRODUCTION METHOD | 2021 |
|
RU2767030C1 |
EXOGENIC-INDUCED ANIMAL MODEL OF ALZHEIMER DISEASE | 2012 |
|
RU2532525C2 |
METHOD FOR PREDICTION OF RISK OF EMBOLOGENIC RAPTURE OF CAROTID ATHEROSCLEROTIC PLAQUE | 2019 |
|
RU2729733C1 |
METHOD FOR PREDICTING EMBOLIC HAZARD OF UNSTABLE CAROTID ATHEROSCLEROTIC PLAQUE | 2019 |
|
RU2723741C1 |
Authors
Dates
2013-10-10—Published
2012-04-18—Filed